Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors
Crossref DOI link: https://doi.org/10.1007/s15010-016-0962-3
Published Online: 2016-11-16
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Boglione, Lucio
Pinna, Simone Mornese
Cardellino, Chiara Simona
De Nicolò, Amedeo
Cusato, Jessica
Carcieri, Chiara
Cariti, Giuseppe
Di Perri, Giovanni
D’Avolio, Antonio
License valid from 2016-11-16